AI assistant
Cigna Group — Director's Dealing 2024
Mar 5, 2024
29918_dirs_2024-03-05_2e3dc025-6b2c-4971-8bad-179ae24d50db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2024-03-01
Reporting Person: Cordani David (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-01 | Common Stock, $.01 Par Value | A | 35946.0000 | $0.0000 | Acquired | 382656.0000 | Direct |
| 2024-03-01 | Common Stock, $.01 Par Value | F | 6272.0000 | $333.3600 | Disposed | 376384.0000 | Direct |
| 2024-03-01 | Common Stock, $.01 Par Value | F | 16658.0000 | $333.3600 | Disposed | 359726.0000 | Direct |
| 2024-03-04 | Common Stock, $.01 Par Value | S | 19288.0000 | $332.6200 | Disposed | 340438.0000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $.01 Par Value | 1727.2938 | Indirect |
| Common Stock, $.01 Par Value | 99918.0000 | Indirect |
| Common Stock, $.01 Par Value | 153801.0000 | Indirect |
Footnotes
F1: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F2: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F3: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
F4: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023.
F5: Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.